Catane, Glennalyn G.

HRN: 11-87-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2024
CEFUROXIME 750MG (VIAL)
07/28/2024
08/04/2024
750MG
Iv
Q8
UTI
Waiting Final Action 
08/01/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
08/01/2024
08/04/2024
PO
5 Ml
Q12
URINARY TRACT INFECTION
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: